WHITNEY COULTAS: Open Payments
NPI 1053088575 · MEDFORD, OR. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$249 in 10 payments from 8 companies in 2025. Trend: 2023 $112 · 2024 $252 · 2025 $249
Food & beverage: $159Education: $90
| Company | Payments | Amount |
|---|---|---|
| Astellas Pharma US Inc | 2 | $110 |
| Amgen Inc. | 2 | $38 |
| Xeris Pharmaceuticals, Inc. | 1 | $24 |
| Exact Sciences Corporation | 1 | $17 |
| Lilly USA, LLC | 1 | $17 |
| Novo Nordisk Inc | 1 | $15 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $14 |
| Otsuka America Pharmaceutical, Inc. | 1 | $14 |
Products named: OTEZLA, KEVEYIS, Veozah, The Cologuard Plus Collection Kit, MOUNJARO, Wegovy, Kerendia, REXULTI.
Industry payments across OR — which companies pay providers there.
